Hi team,
On the long term hold perspective perhaps something else to consider. I spoke with my accountant about the potential changes to capital gains tax should Labour take the helm in the upcoming election. He advised me that current understanding is that current holdings will be ‘grandfathered’ ie subject to the CG tax laws present at time of purchase where as new holdings will have the new law applied (tax on 75% profit after 1 year hold instead of on current 50%).
A question to the group. In the announcement the content under Hygea refers to Gmedical patch (extender halter monitor). Commentary under the Chinese facility heading refers to GMV patch products. I know what a halter monitor is, and initially assumed that halter monitor referred to the patch that is placed on the chest to monitor ECG, ie one of many GMV patch products. Is this assumption correct or is the halter monitor an existing product within the portfolio of the recently acquired monitoring facilities used for testing of proof of concept ie comms, algorithm, work flow etc and the real patch is yet to be delivered? I did a quick search and couldn’t find a specific reference to Gmedical patch (extender halter monitor). But it was a quick search.
- Forums
- ASX - By Stock
- GMV
- Ann: Quarterly Activities and Cashflow Report
Ann: Quarterly Activities and Cashflow Report, page-63
-
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online